DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Arimidex (Anastrozole) - Current Clinical Trials

 
 



Arimidex Related Clinical Trials

Arimidex With or Without Faslodex In Postmenopausal Women With HR Positive Breast Cancer [Active, not recruiting]

Bioequivalence Study Comparing Arimidex Tablet and Anastrozole ODF in Japanese Healthy Male Subjects [Completed]

Liver Safety Under Upfront Arimidex vs Tamoxifen [Completed]

A Global Study to Compare the Effects of Fulvestrant and Arimidex in a Subset of Patients With Breast Cancer. [Active, not recruiting]

Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid [Active, not recruiting]

Arimidex/Faslodex/Iressa Study: A Trial Using Arimidex, Faslodex and Iressa in Women With Breast Cancer [Terminated]

MK2206 in Combination With Anastrozole, Fulvestrant, or Anastrozole and Fulvestrant in Treating Postmenopausal Women With Metastatic Breast Cancer [Active, not recruiting]

Arimidex Multicenter Trial in Growth Hormone (GH) Deficient Boys [Completed]

Anti-tumour Effects & Tolerability of Faslodex Alone or in Combination With Arimidex in Post Menopausal Women Prior to Surgery for Primary Breast Cancer [Completed]

Arimidex/Tamoxifen Neo Adjuvant Study in Premenopausal Patients With Breast Cancer Under Anti Hormonal Treatment [Completed]

ATAC - Arimidex, Tamoxifen Alone or in Combination [Completed]

Ax-003/Arimidex (Anastrozole) in the Adjuvant Therapy of Early Breast Cancer [Completed]

Anastrozole 1 mg Tablets Under Fasting Conditions [Completed]

A Study to Evaluate the Efficacy and Safety of Herceptin® (Trastuzumab) in Combination With Arimidex® (Anastrozole) an Aromatase Inhibitor Compared to Arimidex® Alone in Patients With Metastatic Breast Cancer [Completed]

Bioavailability Study of Anastrozole Tablets 1 mg of Dr.Reddy's Under Fed Conditions [Completed]

Bioavailability Study of Anastrozole Tablets 1 mg of Dr.Reddy's Under Fasting Conditions [Completed]

Effectiveness of Combination of Arimidex and Nolvadex in Adjuvant Therapy of Breast Carcinoma in Postmenopausal Women. [Completed]

Fulvestrant Combined Anastrozole Versus Anastrozole in Luminal A-like Postmenopausal ABC [Recruiting]

STARS Breast Trial (Study of Anastrozole and Radiotherapy Sequencing) [Recruiting]

Anastrozole 1 mg Tablets Under Fed Conditions [Completed]

Different Durations of Adjuvant Anastrozole Therapy After 2 to 3 Years Tamoxifen Therapy in Breast Cancer [Active, not recruiting]

Arimidex Therapy Compliance Electronic Monitoring System [Completed]

The Study of Goserelin Plus Fulvestrant Comparing With Goserelin Plus Anastrozole for Advanced Breast Cancer [Recruiting]

Treatment of Sexual Dysfunction in Men With Epilepsy With Testosterone and Either Arimidex or Placebo [Completed]

Fulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung Cancer [Terminated]

Anti-Hormone Therapy (With Anastrazole and Fulvestrant) Before Surgery to Treat Postmenopausal Women With Breast Cancer. [Recruiting]

Arthralgia During Anastrozole Therapy for Breast Cancer [Completed]

Bevacizumab Given With Either Anastrozole or Fulvestrant With Trastuzumab for Postmenopausal Metastatic Breast Cancer [Completed]

A Pharmacokinetic and Randomized Trial of Neoadjuvant Treatment With Anastrozole Plus AZDO530 in Postmenopausal Patients With Hormone Receptor Positive Breast Cancer [Recruiting]

Anastrozole in Patients With Pulmonary Arterial Hypertension [Active, not recruiting]

Iressa (ZD1839) Plus Anastrozole (Arimidex) in Patients With Ovarian Cancer [Completed]

PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer [Recruiting]

To Assess Safety and Effect of Olaparib on the Pharmacokinetics of Anastrozole, Letrozole & Tamoxifen, and Their Effect on Olaparib, in Patients With Advanced Solid Cancer [Active, not recruiting]

Study of Faslodex With or Without Concomitant Arimidex Versus Exemestane Following Progression on Non-steroidal Aromatase Inhibitors (NSAI) [Completed]

ATAC - Endometrial Sub-Protocol [Completed]

Akt Inhibitor MK-2206 and Anastrozole With or Without Goserelin Acetate in Treating Patients With Stage II-III Breast Cancer [Recruiting]

Second Line Breast Cancer Trial [Completed]

Anastrozole and ZD1839 Compared With Fulvestrant and ZD1839 in Postmenopausal Women w/ Metastatic Breast Cancer [Completed]

ATAC - Pharmacokinetics (PK) Sub-Protocol [Completed]

Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer [Terminated]

Faslodex Advanced Breast Cancer Local Chinese Study [Completed]

Pediatrics Testotoxicosis Study [Bicalutamide Anastrozole Treatment for Testotoxicosis] [Active, not recruiting]

Anastrozole in Treating Postmenopausal Women With DCIS or Stage I-III Breast Cancer [Completed]

Entinostat and Anastrozole in Treating Postmenopausal Women With Triple-Negative Breast Cancer That Can Be Removed by Surgery [Terminated]

Simvastatin and Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ or Invasive Breast Cancer [Completed]

Fulvestrant (F)/Goserelin (G) vs Anastrozole (A)/G vs G for Premenopausal Women [Recruiting]

Adjuvant Tamoxifen Compared With Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ [Active, not recruiting]

Sorafenib and Anastrozole in Treating Postmenopausal Women With Metastatic Breast Cancer [Completed]

Anastrozole and Fulvestrant Compared to Anastrozole as Adjuvant Treatment of Postmenopausal Patients With Breast Cancer [Completed]

Anastrozole Monotherapy Versus Maximal Oestrogen Blockade With Anastrozole and Fulvestrant Combination Therapy [Completed]

Pazopanib Hydrochloride and Anastrozole Before Surgery in Treating Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer [Terminated]

Anastrozole With or Without Gefitinib in Treating Postmenopausal Women With Metastatic or Locally Recurrent Breast Cancer [Completed]

ATAC - Quality of Life Sub-Protocol [Completed]

ATAC - Bone Density Sub-Protocol [Completed]

Feasibility Study of Presurgical Hormone Therapy (Anastrozole) in Breast Cancer Patients [Completed]

Anastrozole Plus Lonafarnib (SCH 66336) or Plus Placebo for the Treatment of Advanced Breast Cancer (P03480) [Completed]

Estradiol Suppression for the Treatment of Metastatic Breast Cancer in Premenopausal Women [Completed]

Anastrozole Administration in Elderly Hypogonadal Men [Completed]

Bioequivalency Study of Anastrozole 1 mg Under Fed Conditions [Completed]

Bioequivalency Study of Anastrozole 1 mg Under Fasted Conditions [Completed]

Chemoprevention Trial - Anastrozole in Ductal Carcinoma In Situ (DCIS) in Postmenopausal Women [Active, not recruiting]

Evaluation of Antiproliferative Effects of Arimidex in Ductal Lavage Fluid in Patients With Breast Cancer [Completed]

Arimidex Bone Mass Index and Oral Bisphosphonates [Completed]

Anastrozole Reduced Proliferation and Progesterone Receptor Indexes in Short Term Hormone Therapy [Completed]

Safety Study of Enzalutamide (MDV3100) in Patients With Incurable Breast Cancer [Active, not recruiting]

Anastrazole Plus GnRH-agonist in the Treatment of Endometriosis Recurrence [Recruiting]

Study of Anastrozole, Letrozole, or Exemestane With or Without Tamoxifen in Treating Postmenopausal Women With Hormone-Responsive Breast Cancer That Has Been Completely Removed By Surgery [Active, not recruiting]

Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer [Terminated]

Aromasin Vs Arimidex Study As Initial Hormonal Therapy In Postmenopausal Women With Advanced/Recurrent Breast Cancer [Completed]

Bioequivalence Study of Anastrozole 1 mg Tablet [Completed]

Phase II Anastrozole and ZD6474 in Neoadjuvant Treatment of Postmenopausal Hormone Receptor-Positive Breast Cancer [Terminated]

Aromatase Inhibitor in Bone Maturation, Children With Silver Russell or Prader-Willi Syndrome [Active, not recruiting]

Bisphosphonate and Anastrozole Trial - Bone Maintenance Algorithm Assessment [Completed]

Antiestrogen vs Aromatase Inhibitor After Adjuvant Chemotherapy for Breast Cancer [Terminated]

Comparison of Anastrozole Verses Clomiphene Citrate in Stimulating Follicular Growth and Ovulation in Infertile Women With Ovulatory Dysfunction [Completed]

A Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast Cancer [Not yet recruiting]

Hormone Blockade in Combination With Targeted Agents [Recruiting]

Aromatase Inhibitor Growth Study: Letrozole vs. Anastrozole [Recruiting]

Study of Exemestane After Anastrozole or Letrozole Treatment of Postmenopausal Women With Hormone Responsive Breast Cancer [Recruiting]

Anastrozole and ZD 1839 in Treating Postmenopausal Women With Metastatic Breast Cancer [Completed]

Secondary Adjuvant Long Term Study With Arimidex [Active, not recruiting]

Partial Double-Blind, Placebo-Controlled Study to Assess the Effect of Anastrozole on the Endometrium in Healthy Volunteers [Completed]

AZD4547 & Anastrozole or Letrozole (NSAIs) in ER+ Breast Cancer Patients Who Have Progressed on NSAIs (RADICAL) [Recruiting]

Survey Conducted Among Early Breast Cancer Patients Treated With Arimidex for Evaluation of Treatment Adherence [Completed]

Gene Expression Following Short Term Exposure to Neoadjuvant Endocrine Therapy in Invasive Breast Cancer [Completed]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015